Cargando…
Cardioprotective effects of fibroblast growth factor 21 against doxorubicin-induced toxicity via the SIRT1/LKB1/AMPK pathway
Doxorubicin (DOX) is a highly effective antineoplastic anthracycline drug; however, the adverse effect of the cardiotoxicity has limited its widespread application. Fibroblast growth factor 21 (FGF21), as a well-known regulator of glucose and lipid metabolism, was recently shown to exert cardioprote...
Autores principales: | Wang, Shudong, Wang, Yonggang, Zhang, Zhiguo, Liu, Quan, Gu, Junlian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596591/ https://www.ncbi.nlm.nih.gov/pubmed/28837153 http://dx.doi.org/10.1038/cddis.2017.410 |
Ejemplares similares
-
AMPK potentiation by LKB1 isoforms
por: Thibert, Chantal, et al.
Publicado: (2015) -
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
por: Timm, Kerstin N., et al.
Publicado: (2020) -
Pirfenidone Is an Agonistic Ligand for PPARα and Improves NASH by Activation of SIRT1/LKB1/pAMPK
por: Sandoval‐Rodriguez, Ana, et al.
Publicado: (2020) -
LKB1 suppression promotes cardiomyocyte regeneration via LKB1-AMPK-YAP axis
por: Qu, Shuang, et al.
Publicado: (2022) -
Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2
por: Wang(a), Jie, et al.
Publicado: (2022)